David Duguay

485 total citations
11 papers, 413 citations indexed

About

David Duguay is a scholar working on Endocrine and Autonomic Systems, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Duguay has authored 11 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrine and Autonomic Systems, 3 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Duguay's work include Circadian rhythm and melatonin (5 papers), Coenzyme Q10 studies and effects (2 papers) and Cardiac Ischemia and Reperfusion (2 papers). David Duguay is often cited by papers focused on Circadian rhythm and melatonin (5 papers), Coenzyme Q10 studies and effects (2 papers) and Cardiac Ischemia and Reperfusion (2 papers). David Duguay collaborates with scholars based in Canada, Denmark and United States. David Duguay's co-authors include Nicolas Cermakian, Denis deBlois, Simon S. Wing, Jan Fahrenkrug, Catherine R. Dufour, Vincent Giguère, Lillian J. Eichner, Brian J. Wilson, Valérie Mongrain and Armen Khatchadourian and has published in prestigious journals such as PLoS ONE, British Journal of Pharmacology and PLoS Genetics.

In The Last Decade

David Duguay

11 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Duguay Canada 9 239 122 107 50 46 11 413
Sarah McLoughlin Ireland 8 254 1.1× 167 1.4× 154 1.4× 28 0.6× 18 0.4× 13 434
Irène Yujnovsky France 7 239 1.0× 62 0.5× 137 1.3× 59 1.2× 89 1.9× 9 478
Maoxiang Zhang United States 10 210 0.9× 142 1.2× 278 2.6× 14 0.3× 47 1.0× 15 541
George A. Timmons Ireland 6 334 1.4× 260 2.1× 169 1.6× 22 0.4× 12 0.3× 6 652
Eleonora S. Pagano Argentina 11 127 0.5× 114 0.9× 109 1.0× 131 2.6× 14 0.3× 15 495
David J. Bacsik United States 3 300 1.3× 229 1.9× 144 1.3× 63 1.3× 14 0.3× 5 524
Mitsuaki Hayashi Japan 5 506 2.1× 412 3.4× 62 0.6× 44 0.9× 14 0.3× 9 656
Sonja Langmesser Switzerland 8 206 0.9× 103 0.8× 66 0.6× 56 1.1× 4 0.1× 9 328
Naohiro Kon Japan 8 195 0.8× 97 0.8× 138 1.3× 59 1.2× 6 0.1× 16 373
Elizabeth A. Yu United States 4 326 1.4× 151 1.2× 92 0.9× 113 2.3× 4 0.1× 8 421

Countries citing papers authored by David Duguay

Since Specialization
Citations

This map shows the geographic impact of David Duguay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Duguay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Duguay more than expected).

Fields of papers citing papers by David Duguay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Duguay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Duguay. The network helps show where David Duguay may publish in the future.

Co-authorship network of co-authors of David Duguay

This figure shows the co-authorship network connecting the top 25 collaborators of David Duguay. A scholar is included among the top collaborators of David Duguay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Duguay. David Duguay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Marcotte, Jacques E., et al.. (2015). WS05.4 Video games for positive expiratory pressure (PEP) therapy in children with cystic fibrosis: A pilot study. Journal of Cystic Fibrosis. 14. S9–S9. 2 indexed citations
2.
Duguay, David, et al.. (2014). USP2 Regulates the Intracellular Localization of PER1 and Circadian Gene Expression. Journal of Biological Rhythms. 29(4). 243–256. 34 indexed citations
3.
Duguay, David, Nathalie Bédard, Adeline Rachalski, et al.. (2012). Regulation of behavioral circadian rhythms and clock protein PER1 by the deubiquitinating enzyme USP2. Biology Open. 1(8). 789–801. 37 indexed citations
4.
Duguay, David, et al.. (2011). Dynein Light Chain Tctex-Type 1 Modulates Orexin Signaling through Its Interaction with Orexin 1 Receptor. PLoS ONE. 6(10). e26430–e26430. 23 indexed citations
5.
Dufour, Catherine R., Lillian J. Eichner, Brian J. Wilson, et al.. (2011). Genomic Convergence among ERRα, PROX1, and BMAL1 in the Control of Metabolic Clock Outputs. PLoS Genetics. 7(6). e1002143–e1002143. 85 indexed citations
6.
Duguay, David & Nicolas Cermakian. (2009). THE CROSSTALK BETWEEN PHYSIOLOGY AND CIRCADIAN CLOCK PROTEINS. Chronobiology International. 26(8). 1479–1513. 177 indexed citations
7.
Duguay, David, Stéphanie Pesant, Christian F. Deschepper, & Denis deBlois. (2007). Fibroblast apoptosis precedes cardiomyocyte mass reduction during left ventricular remodeling in hypertensive rats treated with amlodipine. Journal of Hypertension. 25(6). 1291–1299. 11 indexed citations
8.
Duguay, David, Ahmed Ménaouar, Bogdan Danalache, et al.. (2007). Control of left ventricular mass by moxonidine involves reduced DNA synthesis and enhanced DNA fragmentation. British Journal of Pharmacology. 153(3). 459–467. 10 indexed citations
9.
Duguay, David & Denis deBlois. (2007). Differential regulation of Akt, caspases and MAP kinases underlies smooth muscle cell apoptosis during aortic remodelling in SHR treated with amlodipine. British Journal of Pharmacology. 151(8). 1315–1323. 17 indexed citations
10.
11.
Sarkissian, Shant Der, et al.. (2004). Synergistic interaction between enalapril, L‐arginine and tetrahydrobiopterin in smooth muscle cell apoptosis and aortic remodeling induction in SHR. British Journal of Pharmacology. 142(5). 912–918. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah McLoughlin Breakdown of academic impact, for papers by Irène Yujnovsky Breakdown of academic impact, for papers by Maoxiang Zhang Breakdown of academic impact, for papers by George A. Timmons Breakdown of academic impact, for papers by Eleonora S. Pagano Breakdown of academic impact, for papers by David J. Bacsik Breakdown of academic impact, for papers by Mitsuaki Hayashi Breakdown of academic impact, for papers by Sonja Langmesser Breakdown of academic impact, for papers by Naohiro Kon Breakdown of academic impact, for papers by Elizabeth A. Yu
Rankless by CCL
2026